The global Proteinase K market is set for significant growth, projected to increase from approximately USD 30.2 million in 2025 to USD 48.2 million by 2035, representing a steady CAGR of 4.8% over the ...

KALA's lead product candidate, KPI-012, contains growth factors, protease inhibitors, matrix proteins and neurotrophic factors to potentially correct the impaired corneal healing that is an underlying ...